Robeco Institutional Asset Management B.V. lowered its stake in shares of Align Expertise, Inc. (NASDAQ:ALGN – Free Report) by 11.7% throughout the fourth quarter, in keeping with the corporate in its most up-to-date Kind 13F submitting with the Securities and Alternate Fee (SEC). The institutional investor owned 63,479 shares of the medical tools supplier’s inventory after promoting 8,423 shares throughout the quarter. Robeco Institutional Asset Management B.V. owned about 0.08% of Align Expertise price $174,000 as of its most up-to-date submitting with the Securities and Alternate Fee (SEC).
A number of different institutional traders and hedge funds have additionally purchased and bought shares of ALGN. Rhenman & Companions Asset Management AB acquired a brand new stake in Align Expertise in the third quarter price about $305,000. Ameriprise Monetary Inc. grew its stake in shares of Align Expertise by 348.9% throughout the third quarter. Ameriprise Monetary Inc. now owns 756,393 shares of the medical tools supplier’s inventory price $230,938,000 after buying an extra 587,886 shares in the final quarter. Invesco Ltd. grew its stake in shares of Align Expertise by 15.4% throughout the third quarter. Invesco Ltd. now owns 960,271 shares of the medical tools supplier’s inventory price $293,190,000 after buying an extra 128,273 shares in the final quarter. Quadrature Capital Ltd bought a brand new stake in Align Expertise in the third quarter valued at $35,499,000. Lastly, DAVENPORT & Co LLC raised its holdings in shares of Align Expertise by 5,179.5% in the fourth quarter. DAVENPORT & Co LLC now owns 114,671 shares of the medical tools supplier’s inventory valued at $31,576,000 after shopping for an extra 112,499 shares over the last quarter. 88.43% of the inventory is owned by hedge funds and different institutional traders.
Insider Shopping for and Promoting at Align Expertise
In different Align Expertise information, Director Joseph Lacob bought 15,000 shares of the agency’s inventory in a transaction dated Thursday, February twenty ninth. The shares have been bought at a median worth of $303.22, for a complete worth of $4,548,300.00. Following the completion of the sale, the director now owns 131,994 shares in the corporate, valued at roughly $40,023,220.68. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which is obtainable at this hyperlink. Insiders personal 0.62% of the corporate’s inventory.
Wall Road Analyst Weigh In
A number of analysis analysts have weighed in on ALGN shares. Stifel Nicolaus upped their goal worth on shares of Align Expertise from $350.00 to $400.00 and gave the inventory a “purchase” ranking in a analysis report on Thursday, April 18th. Piper Sandler restated an “obese” ranking and set a $375.00 goal worth (up from $355.00) on shares of Align Expertise in a analysis report on Thursday, April twenty fifth. Morgan Stanley elevated their worth goal on shares of Align Expertise from $344.00 to $360.00 and gave the corporate an “obese” ranking in a analysis report on Thursday, April twenty fifth. The Goldman Sachs Group elevated their worth goal on shares of Align Expertise from $197.00 to $225.00 and gave the corporate a “promote” ranking in a analysis report on Friday, February 2nd. Lastly, Leerink Partnrs reiterated a “market carry out” ranking on shares of Align Expertise in a analysis report on Monday, February twenty sixth. One funding analyst has rated the inventory with a promote ranking, three have assigned a maintain ranking and 7 have issued a purchase ranking to the corporate. In keeping with MarketBeat.com, the inventory has a consensus ranking of “Reasonable Purchase” and a consensus goal worth of $353.00.
Read Our Latest Research Report on ALGN
Align Expertise Buying and selling Up 1.3 %
ALGN stock opened at $255.62 on Friday. The agency’s 50-day shifting common is $299.95 and its two-hundred day shifting common is $276.22. Align Expertise, Inc. has a 52 week low of $176.34 and a 52 week excessive of $413.20. The corporate has a market capitalization of $19.24 billion, a price-to-earnings ratio of 42.11, a price-to-earnings-growth ratio of 4.80 and a beta of 1.66.
Align Expertise (NASDAQ:ALGN – Get Free Report) final introduced its quarterly earnings information on Wednesday, April twenty fourth. The medical tools supplier reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.08. The agency had income of $997.43 million for the quarter, in comparison with the consensus estimate of $971.97 million. Align Expertise had a internet margin of 11.80% and a return on fairness of 14.15%. On common, equities analysis analysts predict that Align Expertise, Inc. will put up 7.92 earnings per share for the present 12 months.
Align Expertise Firm Profile
Align Expertise, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and companies for orthodontists and common practitioner dentists in the USA, Switzerland, and internationally. The corporate’s Clear Aligner section affords complete merchandise, together with Invisalign complete package deal that addresses the orthodontic wants of youthful sufferers, akin to mandibular development, compliance indicators, and compensation for tooth eruption; and Invisalign First Part I and Invisalign First Complete Part 2 package deal for youthful sufferers usually between the ages of six and ten years, which is a mix of main/child and everlasting tooth.
Featured Articles
Obtain Information & Rankings for Align Expertise Day by day – Enter your e-mail deal with under to obtain a concise every day abstract of the most recent information and analysts’ rankings for Align Expertise and associated firms with MarketBeat.com’s FREE daily email newsletter.